Supplemental material
Emerging Microbes & Infections
Volume 8, 2019 - Issue 1
Original Articles
The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis
Olaniyi Ayobamia Unit 37: Nosocomial Infections, Surveillance of Antimicrobial Resistance and Consumption, Robert Koch-Institute, Berlin, Germany
https://orcid.org/0000-0003-1480-386XView further author information
https://orcid.org/0000-0003-1480-386XView further author information, Niklas Willricha Unit 37: Nosocomial Infections, Surveillance of Antimicrobial Resistance and Consumption, Robert Koch-Institute, Berlin, Germanyhttps://orcid.org/0000-0003-0827-4543View further author information
https://orcid.org/0000-0003-0827-4543View further author information, , Iruka N. Okekeb Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeriahttps://orcid.org/0000-0002-1694-7587View further author information
https://orcid.org/0000-0002-1694-7587View further author information, & Robby Markwarta Unit 37: Nosocomial Infections, Surveillance of Antimicrobial Resistance and Consumption, Robert Koch-Institute, Berlin, GermanyCorrespondence[email protected]
https://orcid.org/0000-0003-0338-3433View further author information
https://orcid.org/0000-0003-0338-3433View further author informationRelated Research Data
Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections.
Source:
Chonnam National University Medical School
Mortality risk factors in burn care units considering the clinical significance of acinetobacter infections.
Source:
Kare Publishing
Results of the European Prevalence of Infection in Intensive Care (EPIC) Study
Source:
American Medical Association (AMA)
Analysis of Acinetobacter baumannii hospital infections in patients treated at the intensive care unit of the University Hospital, Wroclaw, Poland: a 6-year, single-center, retrospective study
Source:
Informa UK Limited
High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa – an update
Source:
Springer Nature
Acinetobacter baumannii in ICU patients: A prospective study highlighting their incidence, antibiotic sensitivity pattern and impact on ICU stay and mortality
Source:
Wolters Kluwer Medknow Publications
A systematic review of the burden of multidrug-resistant healthcare-associated infections among intensive care unit patients in Southeast Asia: The rise of multidrug-resistant acinetobacter baumannii
Source:
Cambridge University Press (CUP)
Acinetobacter Infection
Source:
Massachusetts Medical Society
Incidence of Multidrug-Resistant Organism Among Children Admitted to Pediatric Intensive Care Unit in a Developing Country
Source:
Mary Ann Liebert Inc
National prevalence estimates for resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States.
Source:
Elsevier BV
First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in Egypt.
Source:
Elsevier
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Source:
American Medical Association (AMA)
Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries.
Source:
Hindawi Limited
A point-prevalence survey of healthcare-associated infection in fifty-two Chinese hospitals.
Source:
Elsevier BV
Acinetobacter Infection
Source:
Massachusetts Medical Society
Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement
Source:
Elsevier BV
The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities
Source:
Oxford University Press (OUP)
Hospital-wide comparison of health care-associated infection among 8 intensive care units: A retrospective analysis for 2010-2015.
Source:
Elsevier BV
Intensive care unit-acquired Acinetobacter baumannii infections in a Moroccan teaching hospital: epidemiology, risk factors and outcome.
Source:
Asociatia Pentru Cresterea Vizibilitatii Cercetarii Stiintifice (ACVCS)
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004
Source:
Elsevier BV
L-lysine potentiates aminoglycosides against Acinetobacter baumannii via regulation of proton motive force and antibiotics uptake.
Source:
Informa UK Limited
Local resistance patterns to antimicrobials in internal medicine: a focused report from the REGIMEN (REGistro Infezioni in MEdicina INterna) study
Source:
Springer Science and Business Media LLC
The Burden of Healthcare-Associated Infections in Southeast Asia: A Systematic Literature Review and Meta-analysis
Source:
Oxford University Press (OUP)
Global spread of carbapenem-resistant Acinetobacter baumannii
Source:
Oxford University Press (OUP)
Epidemiological monitoring of nosocomial infections caused by acinetobacter baumannii.
Source:
ScopeMed
The spread of carbapenemase-producing bacteria in Africa: a systematic review
Source:
Oxford University Press (OUP)
Linking provided by
